Trump administration withdraws FDA plan to ban menthol cigarettes

Published 01/24/2025, 11:18 AM
Updated 01/24/2025, 03:25 PM
© Reuters. FILE PHOTO: A man smokes a cigarette while sitting in the Times Square section of New York City, U.S., January 18, 2023. REUTERS/Shannon Stapleton/File Photo
MO
-
BTI
-

By Sriparna Roy and Juveria Tabassum

(Reuters) -The Trump administration has withdrawn a plan to ban menthol cigarettes in the U.S., in a setback to health regulators and activists.

The Food and Drug Administration had in April 2022 proposed to ban the sale of flavored cigars and menthol cigarettes after several health advocacy groups said they were highly addictive, and played a role in luring young people to smoking.

A Jan. 21 filing by the Office of Information and Regulatory Affairs, a White House agency, showed the proposal has been "withdrawn".

Menthol cigarettes, which comprise a third of the industry's total U.S. market share, have also faced scrutiny for their disproportionate impact on the health of Black communities.

"It is deeply disappointing that a final rule was not issued in a timely manner ... it is more critical than ever that states and cities step up their efforts to end the sale of menthol cigarettes and other flavored tobacco products," said Yolonda Richardson, CEO of Campaign for Tobacco-Free Kids.

The FDA sent their final version of the regulation to the White House's Office of Management and Budget in October 2023, which then awaited a sign off from the Biden administration.

The White House, however, agreed to hold dozens of meetings with groups opposing the rule, including civil rights advocates, business owners and law enforcement officials, with the government missing deadlines in December 2023 and March 2024 to issue a final rule on the ban.

A ban would have likely cost billions of dollars in annual revenue for cigarette companies such as Altria (NYSE:MO) and British American Tobacco (NYSE:BTI).

© Reuters. FILE PHOTO: A man smokes a cigarette while sitting in the Times Square section of New York City, U.S., January 18, 2023. REUTERS/Shannon Stapleton/File Photo

"A menthol ban would fuel yet another extensive illicit market for unregulated and potentially more dangerous products in the U.S., similar to the thriving illicit market of disposable vapor products that FDA has struggled to enforce," said Reynolds American (NYSE:RAI), BATS' U.S. subsidiary in an emailed statement.

Altria declined to comment, while the FDA pointed to a temporary pause in public communications due to the transition to a new team.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.